Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Cancer Causes & Control : CCC|May 1, 1993
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective studyT Lehtinen, J Lumio, J Dillner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 2, 1998
Common and emerging infectious causes of hematological malignancies in the youngT Lehtinen, M Lehtinen
Archives of Virology|January 1, 1987
Expression of the HSV specified major DNA-binding protein in virus infected RAJI and VERO cellsM Lehtinen, P Kulomaa, T Lehtinen
Journal of Medical Virology|July 1, 1985
Serum antibodies to the major HSV-2-specified DNA-binding protein in patients with an acute HSV infection or cervical neoplasiaM Lehtinen, T Lehtinen, V Koivisto, et al.
Intervirology|January 1, 1985
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2M Lehtinen, V Koivisto, T Lehtinen, et al.
Hematological Oncology|September 1, 1992
Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphomaT Lehtinen, J Isola, R Aine, et al.
Acta Virologica|November 1, 1984
Purification of herpes simplex virus-specified major DNA-binding proteins and detection of antibodies to them in human and rabbit seraM Lehtinen, T Lehtinen, V Koivisto, et al.
British Journal of Haematology|April 1, 1996
Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid originT Lehtinen, T Luostarinen, J Dillner, et al.
Journal of Medical Virology|August 1, 1994
Antibody response to adenovirus E1b-derived synthetic peptides and serum levels of p53 in patients with gastrointestinal and other malignant lymphomasM L Lähdeaho, T Lehtinen, R Aine, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Evaluation of plasma levels of thymidine kinase and mutated p53 in 81 patients with newly diagnosed malignant lymphomaT Lehtinen, R Aine, P Kellokumpu-Lehtinen, et al.
Pageof 28